Market Research Logo

Global Respiratory Disease Testing Market 2015-2019

Global Respiratory Disease Testing Market 2015-2019

About respiratory disease testing

The respiratory system of the body plays a vital role in eliminating carbon dioxide and toxic wastes, regulates the temperature, and establishes a stabilized blood acid-alkaline balance. Respiratory diseases such as asthma, bronchitis, COPD occur due to acute or chronic defects in the respiratory system. The respiratory testing devices help in detecting chronic or acute respiratory diseases; therefore, the necessary treatment can be provided to people suffering from respiratory damages.

Respiratory tests such as imaging, spirometry, peak flow test, blood gas test, lung volume, and few other tests are used to diagnose the respiratory disease. Globally, there has been growing incidences of respiratory diseases such as asthma and COPD. Around 235 million people globally are suffering from asthma, and there have been around 3 million deaths worldwide due to COPD. This indicates an alarming increase in the respiratory disorders worldwide due to high pollution and increased tobacco consumption.

These factors result in increased demand for the respiratory testing devices and propel the market growth.

Technavio's analysts forecast the global respiratory disease testing market to grow at a CAGR of 7.46% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global respiratory disease testing market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of testing devices used to diagnose acute and chronic respiratory diseases.

The market is segmented based on the type of test:

Mechanical/screening tests

  • Spirometry test
  • Peak flow test
  • Blood gas test
  • Lung volume test
  • OSA diagnostic tests
IVD tests
  • Molecular diagnostic test
  • POC test
  • Others
Technavio's report, Global Respiratory Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA, and APAC; it also covers the landscape of the global respiratory disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
  • Americas
  • APAC
  • EMEA
Key vendors
  • Alere
  • CareFusion
  • Nihon Kohden
  • Philips Healthcare
  • Smiths Medical
Other prominent vendors
  • Abbott
  • Affymetrix
  • Cepheid
  • COSMED
  • Covidien
  • F. Hoffmann-La Roche
  • Futuremed America
  • Instrumentation Laboratories
  • ndd Medical Technology
  • SDI Diagnostics
  • Seegene
  • Siemens Healthcare
Key market driver
  • Increase in respiratory disorders worldwide
  • For a full, detailed list, view our report
Key market challenge
  • Use of low-cost testing products
  • For a full, detailed list, view our report
Key market trend
  • Initiatives and programs to create awareness
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Respiratory Disease Testing Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Respiratory Disease Testing Market: Alere, CareFusion, COSMED, Nihon Kohden, Philips Healthcare and Smiths Medical

Other Prominent Vendors in the market are: Diamedix, Affymetrix, Seegene, Cepheid, NDD Medical Technologies, COSMED, Abbott, F. Hoffmann-La Roche, Siemens Healthcare, Instrumentation Laboratories, Covidien, SDI Diagnostics, and Futuremed America.

Commenting on the report, an analyst from Technavio’s team said: “Multiplex devices are used to detect two or more respiratory disease-causing pathogens at the same time. These systems provide sensitive and comprehensive diagnosis, positively influencing patient care and the drug delivery system. RespiFinder RG panel by QIAGEN is one of the multiplex device that can detect 21 pathogens causing respiratory diseases such as acute respiratory tract infection in four hours.”

According to the report, the consumption of tobacco, particularly in the form of cigarettes, is a major cause of chronic respiratory diseases worldwide. Annually, tobacco consumption results in about six million deaths worldwide. Of this number, about five million individuals die due to direct tobacco consumption while 0.6 million people die due to passive smoking. Research studies report that tobacco consumption is high in developing countries compared to developed countries.

Further, the report states that automation in respiratory disease testing is fast gaining momentum due to its limited turnaround time. However, automated instruments are associated with high purchase, installation, maintenance, and upgrading costs. The availability of funds for the development and maintenance of these testing devices is low. Coupled with this, the lack of standards for comparison is lowering the accuracy and specificity of tests for the detection of disease-causing pathogens.

Companies Mentioned

Alere, CareFusion, COSMED, Nihon Kohden, Philips Healthcare, Smiths Medical, Diamedix, Affymetrix, Seegene, Cepheid, NDD Medical Technologies, COSMED, Abbott, F. Hoffmann-La Roche, Siemens Healthcare, Instrumentation Laboratories, Covidien, SDI Diagnostics, Futuremed America.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
      • Table Overview of global respiratory disease testing market
      • Table Global respiratory disease testing market 2014-2019 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by test
    • Table Global respiratory disease testing market by test
    • Table Global respiratory disease testing market by test type 2014
  • Market segmentation by mechanical and screening test
    • Market size and forecast
      • Table Global respiratory disease testing market by mechanical and screening test 2014-2019 ($ billions)
      • Table Global respiratory disease testing market by spirometry 2014-2019 ($ millions)
      • Table Global respiratory disease testing market by peak flow test 2014-2019 ($ millions)
      • Table Global respiratory disease testing market by blood gas test 2014-2019 ($ millions)
      • Table Global respiratory disease testing market by pulmonary function test 2014-2019 ($ millions)
      • Table Global respiratory disease testing market by OSA diagnostic test 2014-2019 ($ millions)
  • Market segmentation by IVD test
    • Molecular diagnostic tests
    • POC tests
    • Other tests
      • Table Global respiratory disease testing market by IVD test 2014
  • Geographical segmentation
    • Global respiratory testing market segmentation by geography
      • Table Global respiratory disease testing market segmentation by geography 2014
      • Table Respiratory disease testing market in Americas 2014-2019 ($ billions)
      • Table Respiratory disease testing market in EMEA 2014-2019 ($ billions)
      • Table Respiratory disease testing market in APAC 2014-2019 ($ billions)
  • Market drivers
    • Prevalence of chronic respiratory diseases
    • Rise in air pollution
    • Increased consumption of tobacco
    • Government measures for improving healthcare services
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Use of cost-effective products
    • Biocompatibility complications during product design
    • Lack of standard procedure and funds
    • Pricing pressure through price ceilings
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Initiatives and programs to spread awareness
    • Use of multiplex devices
    • Preference for portable devices
    • Popularity of POC devices
  • Vendor landscape
    • Competitive scenario
    • Key prominent vendors
      • Table Alere: Key takeaways
      • Table CareFusion: Key takeaways
      • Table Nihon Kohden: Key takeaways
      • Table Philips Healthcare: Key takeaways
      • Table Smiths Medical: Key takeaways
    • Other prominent vendors
  • Key vendor analysis
    • Alere
      • Table Alere: Business segmentation by revenue 2014
      • Table Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
    • CareFusion
    • Nihon Kohden
      • Table Nihon Kohden: Business segmentation by revenue 2015
      • Table Nihon Kohden: Business segmentation by revenue 2014 and 2015 ($ millions)
      • Table Nihon Kohden: Geographical segmentation by revenue 2015
    • Philips Healthcare
      • Table Philips Healthcare: Business segmentation by revenue 2014
    • Smiths Medical
      • Table Smiths Medical: Business segmentation by revenue 2014
      • Table Smiths Medical: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report